1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Intermittent Claudication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Medication Therapies
  • 1.2.3 Revascularization
• 1.3 Market by Application
  • 1.3.1 Global Intermittent Claudication Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Home Healthcare
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Intermittent Claudication Market Perspective (2016-2027)
• 2.2 Intermittent Claudication Growth Trends by Regions
  • 2.2.1 Intermittent Claudication Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Intermittent Claudication Historic Market Share by Regions (2016-2021)
  • 2.2.3 Intermittent Claudication Forecasted Market Size by Regions (2022-2027)
• 2.3 Intermittent Claudication Industry Dynamic
  • 2.3.1 Intermittent Claudication Market Trends
  • 2.3.2 Intermittent Claudication Market Drivers
  • 2.3.3 Intermittent Claudication Market Challenges
  • 2.3.4 Intermittent Claudication Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Intermittent Claudication Players by Revenue
  • 3.1.1 Global Top Intermittent Claudication Players by Revenue (2016-2021)
  • 3.1.2 Global Intermittent Claudication Revenue Market Share by Players (2016-2021)
• 3.2 Global Intermittent Claudication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Intermittent Claudication Revenue
• 3.4 Global Intermittent Claudication Market Concentration Ratio
  • 3.4.1 Global Intermittent Claudication Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Intermittent Claudication Revenue in 2020
• 3.5 Intermittent Claudication Key Players Head office and Area Served
• 3.6 Key Players Intermittent Claudication Product Solution and Service
• 3.7 Date of Enter into Intermittent Claudication Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Intermittent Claudication Breakdown Data by Type

• 4.1 Global Intermittent Claudication Historic Market Size by Type (2016-2021)
• 4.2 Global Intermittent Claudication Forecasted Market Size by Type (2022-2027)

5 Intermittent Claudication Breakdown Data by Application

• 5.1 Global Intermittent Claudication Historic Market Size by Application (2016-2021)
• 5.2 Global Intermittent Claudication Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Intermittent Claudication Market Size (2016-2027)
• 6.2 North America Intermittent Claudication Market Size by Type
  • 6.2.1 North America Intermittent Claudication Market Size by Type (2016-2021)
  • 6.2.2 North America Intermittent Claudication Market Size by Type (2022-2027)
  • 6.2.3 North America Intermittent Claudication Market Size by Type (2016-2027)
• 6.3 North America Intermittent Claudication Market Size by Application
  • 6.3.1 North America Intermittent Claudication Market Size by Application (2016-2021)
  • 6.3.2 North America Intermittent Claudication Market Size by Application (2022-2027)
  • 6.3.3 North America Intermittent Claudication Market Size by Application (2016-2027)
• 6.4 North America Intermittent Claudication Market Size by Country
  • 6.4.1 North America Intermittent Claudication Market Size by Country (2016-2021)
  • 6.4.2 North America Intermittent Claudication Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Intermittent Claudication Market Size (2016-2027)
• 7.2 Europe Intermittent Claudication Market Size by Type
  • 7.2.1 Europe Intermittent Claudication Market Size by Type (2016-2021)
  • 7.2.2 Europe Intermittent Claudication Market Size by Type (2022-2027)
  • 7.2.3 Europe Intermittent Claudication Market Size by Type (2016-2027)
• 7.3 Europe Intermittent Claudication Market Size by Application
  • 7.3.1 Europe Intermittent Claudication Market Size by Application (2016-2021)
  • 7.3.2 Europe Intermittent Claudication Market Size by Application (2022-2027)
  • 7.3.3 Europe Intermittent Claudication Market Size by Application (2016-2027)
• 7.4 Europe Intermittent Claudication Market Size by Country
  • 7.4.1 Europe Intermittent Claudication Market Size by Country (2016-2021)
  • 7.4.2 Europe Intermittent Claudication Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Intermittent Claudication Market Size (2016-2027)
• 8.2 Asia-Pacific Intermittent Claudication Market Size by Type
  • 8.2.1 Asia-Pacific Intermittent Claudication Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Intermittent Claudication Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Intermittent Claudication Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Intermittent Claudication Market Size by Application
  • 8.3.1 Asia-Pacific Intermittent Claudication Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Intermittent Claudication Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Intermittent Claudication Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Intermittent Claudication Market Size by Region
  • 8.4.1 Asia-Pacific Intermittent Claudication Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Intermittent Claudication Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Intermittent Claudication Market Size (2016-2027)
• 9.2 Latin America Intermittent Claudication Market Size by Type
  • 9.2.1 Latin America Intermittent Claudication Market Size by Type (2016-2021)
  • 9.2.2 Latin America Intermittent Claudication Market Size by Type (2022-2027)
  • 9.2.3 Latin America Intermittent Claudication Market Size by Type (2016-2027)
• 9.3 Latin America Intermittent Claudication Market Size by Application
  • 9.3.1 Latin America Intermittent Claudication Market Size by Application (2016-2021)
  • 9.3.2 Latin America Intermittent Claudication Market Size by Application (2022-2027)
  • 9.3.3 Latin America Intermittent Claudication Market Size by Application (2016-2027)
• 9.4 Latin America Intermittent Claudication Market Size by Country
  • 9.4.1 Latin America Intermittent Claudication Market Size by Country (2016-2021)
  • 9.4.2 Latin America Intermittent Claudication Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Intermittent Claudication Market Size (2016-2027)
• 10.2 Middle East & Africa Intermittent Claudication Market Size by Type
  • 10.2.1 Middle East & Africa Intermittent Claudication Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Intermittent Claudication Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Intermittent Claudication Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Intermittent Claudication Market Size by Application
  • 10.3.1 Middle East & Africa Intermittent Claudication Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Intermittent Claudication Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Intermittent Claudication Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Intermittent Claudication Market Size by Country
  • 10.4.1 Middle East & Africa Intermittent Claudication Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Intermittent Claudication Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 I'ROM GROUP(DNAVEC Corporation)
  • 11.1.1 I'ROM GROUP(DNAVEC Corporation) Company Details
  • 11.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
  • 11.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Introduction
  • 11.1.4 I'ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2016-2021)
  • 11.1.5 I'ROM GROUP(DNAVEC Corporation) Recent Development
• 11.2 Nuo Therapeutics Inc.
  • 11.2.1 Nuo Therapeutics Inc. Company Details
  • 11.2.2 Nuo Therapeutics Inc. Business Overview
  • 11.2.3 Nuo Therapeutics Inc. Intermittent Claudication Introduction
  • 11.2.4 Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021)
  • 11.2.5 Nuo Therapeutics Inc. Recent Development
• 11.3 Kowa Company Ltd.
  • 11.3.1 Kowa Company Ltd. Company Details
  • 11.3.2 Kowa Company Ltd. Business Overview
  • 11.3.3 Kowa Company Ltd. Intermittent Claudication Introduction
  • 11.3.4 Kowa Company Ltd. Revenue in Intermittent Claudication Business (2016-2021)
  • 11.3.5 Kowa Company Ltd. Recent Development
• 11.4 LTT Bio-Pharma
  • 11.4.1 LTT Bio-Pharma Company Details
  • 11.4.2 LTT Bio-Pharma Business Overview
  • 11.4.3 LTT Bio-Pharma Intermittent Claudication Introduction
  • 11.4.4 LTT Bio-Pharma Revenue in Intermittent Claudication Business (2016-2021)
  • 11.4.5 LTT Bio-Pharma Recent Development
• 11.5 Pluristem Therapeutics Inc.
  • 11.5.1 Pluristem Therapeutics Inc. Company Details
  • 11.5.2 Pluristem Therapeutics Inc. Business Overview
  • 11.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Introduction
  • 11.5.4 Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021)
  • 11.5.5 Pluristem Therapeutics Inc. Recent Development
• 11.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
  • 11.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
  • 11.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
  • 11.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Introduction
  • 11.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2016-2021)
  • 11.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Development
• 11.7 Genovate Biotechnology Co., Ltd.
  • 11.7.1 Genovate Biotechnology Co., Ltd. Company Details
  • 11.7.2 Genovate Biotechnology Co., Ltd. Business Overview
  • 11.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Introduction
  • 11.7.4 Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021)
  • 11.7.5 Genovate Biotechnology Co., Ltd. Recent Development
• 11.8 Novartis AG
  • 11.8.1 Novartis AG Company Details
  • 11.8.2 Novartis AG Business Overview
  • 11.8.3 Novartis AG Intermittent Claudication Introduction
  • 11.8.4 Novartis AG Revenue in Intermittent Claudication Business (2016-2021)
  • 11.8.5 Novartis AG Recent Development
• 11.9 ID Pharma Co., Ltd
  • 11.9.1 ID Pharma Co., Ltd Company Details
  • 11.9.2 ID Pharma Co., Ltd Business Overview
  • 11.9.3 ID Pharma Co., Ltd Intermittent Claudication Introduction
  • 11.9.4 ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2016-2021)
  • 11.9.5 ID Pharma Co., Ltd Recent Development
• 11.10 Helixmith Co., Ltd.
  • 11.10.1 Helixmith Co., Ltd. Company Details
  • 11.10.2 Helixmith Co., Ltd. Business Overview
  • 11.10.3 Helixmith Co., Ltd. Intermittent Claudication Introduction
  • 11.10.4 Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021)
  • 11.10.5 Helixmith Co., Ltd. Recent Development
• 11.11 G. Pohl-Boskamp GmbH & Co. KG
  • 11.11.1 G. Pohl-Boskamp GmbH & Co. KG Company Details
  • 11.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
  • 11.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Introduction
  • 11.11.4 G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2016-2021)
  • 11.11.5 G. Pohl-Boskamp GmbH & Co. KG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Intermittent Claudication Scope and Market Size
Intermittent Claudication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intermittent Claudication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Treatment Process
Medication Therapies
Revascularization
by Drug Type
ALD-301
DVC1-0101
K-134
LT-0101
PLX-PAD
Tirasemtiv

Segment by Application
Hospitals
Clinics
Home Healthcare
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
I'ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc.
Kowa Company Ltd.
LTT Bio-Pharma
Pluristem Therapeutics Inc.
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis AG
ID Pharma Co., Ltd
Helixmith Co., Ltd.
G. Pohl-Boskamp GmbH & Co. KG